Effectiveness of treatment was analyzed by contrasting each Topamax ® treatment group to inactive medicine (ITT population) for the percent decrease from baseline to the last 12 weeks of the double-blind phase in the monthly migraine attack rate (key endpoint).

This suggests that breastfeeding or expectant females should first speak with their healthcare company and weight up all the dangers and benefits linked with the treatment - and just then begin taking this medicine.

Read More    |    Comments

These are not all the feasible adverse effects of Topamax.

Read More    |    Comments

[Ref] The main therapy of cases of secondary angle closing glaucoma source by topiramate is discontinuation of the drug.

Read More    |    Comments

Within 24 hours, the stool frequency declined to 2 to 3 times daily, more solid and the shade and odor stabilized.

Read More    |    Comments